Annual Drug Patent Expirations for AVANDARYL
Avandaryl is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
The generic ingredient in AVANDARYL is glimepiride; rosiglitazone maleate. Additional details are available on the glimepiride; rosiglitazone maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com